Scleroderma study: Hope for a longer life for patients with rare autoimmune disorderJanuary 12, 2018
An unusual autoimmune disease that causes skin and lung damage can be treated effectively by stem cell transplant, a new study in the New England Journal of Medicine has found. The approach could represent the first new treatment to improve survival in patients with severe scleroderma in more than four decades.
The experimental procedure uses chemotherapy and radiation to destroy the body's malfunctioning immune system, then replaces it via a stem-cell transplant. The stem cells are taken from the patient's own blood and given back to the patient after the chemotherapy.
In a multisite clinical trial, the approach proved more successful than the existing treatment, significantly improving survival and reported quality of life. "This is a major advance in the treatment of severe scleroderma," said Karen Ballen, MD, a co-investigator on the study and the director of stem cell transplantation at the University of Virginia Cancer Center.
The study compared the most effective existing treatment, the drug cyclophosphamide, with the new approach. Thirty-four trial participants received cyclophosphamide, while 33 received the stem cell transplant treatment. After 72 months, 86 percent of those who received the stem-cell transplant remained alive, compared with only 51 percent of those who received infusions of cyclophosphamide.
In the New England Journal of Medicine paper detailing their findings, the researchers conclude: "At four and a half years of follow up, participants who received a transplant experienced significantly better outcomes overall than those who received cyclophosphamide. In addition, 44 percent of participants who received cyclophosphamide had begun taking anti-rheumatic drugs for progression of their scleroderma, compared to only 9 percent of those who received a transplant."
Both treatment options carried risks of infections and low blood-cell counts, the researchers reported. The overall infection rates were similar.
All participants had severe scleroderma that affected their lungs or kidneys. The researchers noted that their study had limitations that suggest the findings may not apply to all patients with scleroderma.
The researchers have published their findings in the New England Journal of Medicine. The study was led by Keith Sullivan, MD, of Duke University.
The research was supported by the National Institutes of Health's National Institute of Allergy and Infectious Diseases, grants N01-AI05419, HHSN272201100025C, N01-AI25481, HHSN272200900057C and 1UMZAI117870.
To learn more about scleroderma, visit https://uvahealth.com/services/dermatology/skin-conditions/scleroderma. To keep up with the latest medical research news from UVA, subscribe to the Making of Medicine blog at http://makingofmedicine.virginia.edu.
University of Virginia Health System
Related Scleroderma Articles:
Americans and Norwegians with systemic sclerosis had higher levels of bacteria that can cause inflammation and lower levels of bacteria that are believed to protect against inflammation compared with healthy people.
Michigan State University researchers have discovered that a chemical compound, and potential new drug, reduces the spread of melanoma cells by up to 90 percent.
Researchers at the Stanford University School of Medicine and six other institutions have designed a new diagnostic tool for a rare and deadly autoimmune disease that affects the skin and internal organs.
Samumed, a leader in tissue regeneration, has been selected to feature seven presentations in five different therapeutic areas at the 2016 American College of Rheumatology (ACR) Annual Meeting from Nov.
New and ongoing research at Hospital for Special Surgery in New York City has identified a possible mechanism behind the fibrosis that occurs in scleroderma -- a mechanism that may one day lead to a treatment for the disease.
Female sex hormone clue to fighting serious immune disease
In an article appearing in the May 10, 2016 issue of JAMA, Dinesh Khanna, M.D., of the University of Michigan Scleroderma Program, Ann Arbor, and colleagues evaluated the efficacy of the drug macitentan in reducing the number of new digital ulcers in patients with systemic sclerosis.
Investigators at the Medical University of South Carolina report preclinical findings showing that the M10 peptide reduces collagen production and reverses fibrotic damage due to systemic sclerosis (SSc)-related interstitial lung disease (ILD) in the April 2016 issue of Translational Research.
African-American patients with connective tissue diseases such as lupus or rheumatoid arthritis are twice as likely as white patients to suffer from atherosclerotic blood vessels, which increase the risk of a heart attack, stroke or death.
A clinical trial to test the effectiveness of a stem cell therapy among adults with difficult to treat Crohn's disease has found it is not significantly better than conventional treatment in producing sustained disease remission after one year.
Related Scleroderma Reading:
The Scleroderma Book: A Guide for Patients and Families
by Maureen D. Mayes (Author)
The Scleroderma Book has long been considered the leading source of information for patients suffering with this disease. Now comes the Second Edition of this highly respected volume, extensively revised by Maureen Mayes, M.D., the leading authority in this field.
Writing specifically for patients and their families, Dr. Mayes draws on her extensive experience treating scleroderma to provide up-to-date, practical information that will help patients manage their symptoms and improve their quality of life. Dr. Mayes begins with an easily accessible description of the basic facts,... View Details
Scleroderma: The Proven Therapy that Can Save Your Life
by Henry Scammell (Author)
Scleroderma, which affects as many as 400,000 Americans, starts off like skin cancer but is far more deadly. This new edition is updated with new information about the best therapy for this disease, including the results of the landmark first, and a new, second clinical trial of the only therapy to report reversal and remission of this deadly disease. View Details
The First Year: Scleroderma: An Essential Guide for the Newly Diagnosed (The First Year Series)
by Karen Gottesman (Author), Daniel E. Furst (Foreword)
Sclerodermaa chronic autoimmune condition that causes hardening, thickening, or tightening of the skin and attacks the heart, lungs, kidneys, and gastrointestinal tractis extraordinarily difficult to diagnose and can take a huge toll on the psychological well-being of the individual. From the first moment of her diagnosis, author Karen Gottesman took charge and educated herself on every aspect of her condition. Now, as a "patient-expert," she guides those newly diagnosed step by step through their first year with scleroderma. She provides crucial information about the nature of the... View Details
Scleroderma: From Pathogenesis to Comprehensive Management
by John Varga (Editor), Christopher P. Denton (Editor), Fredrick M. Wigley (Editor), Yannick Allanore (Editor), Masataka Kuwana (Editor)
Comprised of the authoritative work of international experts, this fully-updated second edition of Scleroderma builds upon the well-regarded approach in the first edition to provide integrated, concise, and up-to-date synthesis of current concepts of pathogenesis and modern approaches to management of systemic sclerosis (scleroderma). With a multidisciplinary approach to comprehensive care, this book is easily accessible for health care professionals in many fields. The new edition includes extensive updated material based on major developments in the field, with new chapters on... View Details
SCLERODERMA: Symptoms, Causes, Diagnosis and Effective Treatments – Official Guide from the National Institute of Skin Diseases
This Kindle booklet is for people who have scleroderma, as well as for their family members, friends, and others who want to find out more about the disease. This Kindle booklet describes the different forms of scleroderma and provides information on their symptoms, diagnosis, and treatment, including what patients can do to help manage their disease and the problems associated with it. This booklet also highlights current research efforts into the understanding and treatment of scleroderma, many of which are supported by the National Institute of Arthritis and Musculoskeletal and Skin... View Details
Breathing Again. . . A Joyous Miracle: My Journey with Scleroderma
by Linda M. Edwards (Author)
Focused on her busy career, rising through the ranks of management in high-tech, it was easy for Linda Edwards to dismiss individual symptoms as they appeared, especially when doctors told her they were not life-threatening. Even with her eventual diagnosis of scleroderma, her positive outlook, resilience, and faith kept her pushing through life. It wasn’t until she was facing death, frail, and her breathing compromised, that she realized it would take a miracle to save her. Join Linda on her journey of survival. In Breathing Again… A Joyous Miracle: My Journey with Scleroderma, she... View Details
Voices of Scleroderma, Vol. 3
by International Scleroderma Network (Author)
“I highly recommend this book for patients, caregivers, and medical professionals who want quality medical information and support for scleroderma and related illnesses. “Access to high quality reliable modern information is crucial to patient well-being and outcomes. The realization that ‘you ARE NOT alone’ has therapeutic value in its own right. “The nonprofit International Scleroderma Network (ISN) and its website at www.sclero.org enjoys a well-deserved reputation for top-notch medical and support information and services from both the patient and medical organizations... View Details
If You Have to Wear an Ugly Dress, Learn to Accessorize: Guidance, Inspiration, and Hope for Women with Lupus, Scleroderma, and Other Autoimmune Illnesses
by Linda McNamara (Author), Karen Kemper (Author)
"Lupus and scleroderma are our shadows but they do not define us. We may have to wear the ugly dresses of chronic illness but we don't have to be the ugly dresses." -- Linda and Karen
If you are experiencing a long-term illness or disability, this book is for you -- as well as your family and friends. The authors share a collection of deeply personal stories and poetry to describe their journey from illness to health, well-being, and fruitful living. Their creative life management strategies provide a road map to help you:overcome overwhelming feelings of loss, grief,... View Details
The Scleroderma Book: A Guide for Patients and Families by Maureen D. Mayes (1999-07-15)
by Maureen D. Mayes; (Author)
The Scleroderma Book: A Guide for Patients and Families
by Maureen D. Mayes (Author)
An autoimmune disease in the family with Lupus, Rheumatoid Arthritis, and Polymyositis, Scleroderma afflicts hundreds of thousands of people in the United States. And yet there are very few sources of information for men and women with this disease. Now, in The Scleroderma Book, one of the nation's leading authorities provides a comprehensive guide written specifically for patients and their families.
Dr. Maureen Mayes has drawn on her extensive experience treating scleroderma to provide up-to-date, practical information that will help patients manage their symptoms and... View Details